Estonia showcases digital health leadership at Arab Health 2025
Dubai, United Arab Emirates: Estonia is bringing its pioneering innovations to Arab Health 2025, showcasing advancements in healthtech, set to drive transformative collaboration across the GCC region. Estonia's digital health ecosystem is a testament to how technology can revolutionise healthcare. With 99% of its population health data digitised, Estonia offers solutions that integrate advanced technology into everyday healthcare, making it more efficient, accessible, and person-centered.
Having pioneered a data-driven ecosystem that Ranked #1 in the 2024 Digital Health Index by Bertelsmann Stiftung, Estonia's use of interoperability, AI, and blockchain underscores its role in enhancing healthcare.
"Our fully integrated digital health system empowers every citizen with secure access to their online health records, seamlessly connecting data from healthcare providers across the nation. This initiative exemplifies how a collaborative approach between state-backed innovation and private sector expertise can revolutionize healthcare accessibility and enhance efficiency,' says H.E. Maria Belovas, Ambassador of Estonia to UAE.
GCC's Digital Healthcare Transformation and Collaboration Opportunities
Estonia's participation at Arab Health 2025 highlights opportunities for mutual collaboration with the GCC, leveraging each region's strengths to advance healthcare innovation. The expertise in data-driven healthcare and its successful implementation of digital health models align with the UAE and Saudi Arabia's ambitions to modernise healthcare systems.
By sharing best practices in areas such as e-prescriptions, integrated medical records, and digital health governance, Estonia and the GCC are well-positioned to drive forward their shared visions of healthcare excellence.
Estonian Healthtech Innovations
At Arab Health 2025, Estonia will showcase healthtech innovations from its thriving ecosystem — with the main focus on person-centered care, patient empowerment, and quality of life:
7Sense: A leader in assistive technology, 7Sense empowers visually impaired individuals with a device that provides spatial awareness through tactile feedback. This helps users navigate environments with increased confidence and independence.
MDSC Systems: Designed for emergency scenarios, MDSC Systems provides mobile diagnostic and medical aid units tailored not only for disaster zones and conflict areas, but also remote regions. These lightweight units are equipped with cutting-edge diagnostic tools and telemedicine capabilities, ensuring rapid deployment and effective care delivery even in the most challenging conditions.
Migrevention: Focused on headache disorders, Migrevention's digital clinic employs AI to enhance diagnostics and treatment for migraines and tension-type headaches. By leveraging machine learning, the user-friendly platform offers tailored care plans that address individual patient needs, ensuring improved management of chronic conditions.
Nordic Vitamins: Dedicated to wellness, Nordic Vitamins develops advanced dietary supplements using innovative delivery systems that enhance bioavailability. Their research-driven approach ensures optimal absorption and efficacy, catering to diverse health requirements.
Helmes: Creator of Estonia's pioneering e-prescription system, Helmes connects doctors, pharmacies, and patients to enhance healthcare efficiency. Specialising in healthtech solutions, they also develop self-service pharmacy systems and digital patient portals.
One Architects: Specialising in health-focused architectural design for hospitals and medical centres, One Architects creates healing environments prioritising patient comfort and well-being.
Nortal: Renowned for developing Estonia's National Health Record, Nortal employs blockchain security for data integrity, ensuring transparency in digital systems. Their scalable solutions support seamless data exchange and improve decision-making on every level of the healthcare system.
Chemi-Pharm: A leader in medical-grade hygiene and disinfection, Chemi-Pharm provides innovative and allergen-free solutions essential for infection control in healthcare settings.
Lifeyear: With AI-powered cardiovascular risk assessment tools and remote patient monitoring, Lifeyear transforms chronic disease management through personalised, data-driven care.
Reet Reinart-Okugbeni, a leading R&D expert at Estonia's Applied Research Programme, stated,
"With healthtech solutions from various companies, Estonia's advancements in AI-driven personalised medicine and integrated healthcare systems are leading the way, cementing its role in shaping the future of global healthcare. Estonia is making substantial strides in healthcare by investing in machine learning, predictive analytics, and AI for personalised medicine.'
She added: 'The most important emerging trends encompass real-time health monitoring, blockchain-secured records, and next-generation telemedicine solutions.'
Explore Opportunities at Arab Health 2025
Estonia invites healthcare professionals, investors, and business leaders from the GCC and beyond to discover its cutting-edge healthtech solutions at Arab Health 2025 while opening the door to possible collaborations. Visit Estonia's booth Z5.F30 to engage with companies such as Helmes, Nortal, Migrevention, and 7Sense, and meet Enterprise Estonia representatives to explore opportunities for partnerships and investments in a future where digital health transforms lives globally. For more details on participating companies, visit Trade Estonia's website: tradewithestonia.com/events/arab-health-2025/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
21-04-2025
UAE Healthcare Breaks Ground with Historic Surgeries and Future-Ready Innovations in 2025
The UAE's healthcare sector is cementing its global leadership in 2025 through a string of landmark procedures and groundbreaking innovations across critical specialties. From historic surgeries to futuristic tech, the nation's medical institutions are redefining excellence. Kings College Hospital London Dubai recently performed the city's first liver transplant on a 13-month-old child, born with biliary atresia and a congenital heart defect. The complex case, supported by Al Jalila Foundation, highlights the depth of pediatric expertise now available locally. Cleveland Clinic Abu Dhabi made global headlines with the world's first remotely performed robotic-assisted focal therapy for prostate cancer. Using the Focal-One system, the procedure eliminated the need for invasive surgery. The hospital also carried out the UAE's first simultaneous robotic kidney transplant for donor and recipient using a single robot. Women's health saw a leap forward at Corniche Hospital with a minimally invasive egg collection and freezing procedure, offering a new frontier in fertility care. In regenerative medicine, the Abu Dhabi Stem Cells Centre reported promising results for Type 1 diabetes treatment using umbilical cord-derived stem cells. Major strides were also revealed at Arab Health 2025, where Emirates Health Services introduced two ambitious projects: artificial heart transplantation and pancreatic cell transplantation. Meanwhile, a clinical trial in Abu Dhabi on StromaForte for knee osteoarthritis showed strong potential in cell-based therapy. Looking ahead, M42 will bring heavy ion therapy—among the most advanced cancer treatments—to Cleveland Clinic Abu Dhabi. The hospital also launched a BioButton-powered remote monitoring programme for cancer patients during Abu Dhabi Global Healthcare Week, underscoring the UAE's commitment to personalized, tech-driven care. With AI, robotics, and precision medicine at the forefront, the UAE continues to reshape the future of global healthcare. News Source: Emirates News Agency
Gulf Today
19-04-2025
- Gulf Today
UAE healthcare sector sees massive advancement
The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various specialties. The UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of care. Kings College Hospital London Dubai announced on Thursday the city's first liver transplant on a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). He was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair procedure. Cleveland Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery. In January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one robot. Corniche Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive medicine. The UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy. The Emirates Health Services (EHS) unveiled two innovative projects – an 'Artificial Heart Transplantation' and 'Pancreatic Cell Transplantation' at Arab Health 2025 in January. In April, the Department of Health – Abu Dhabi completed a groundbreaking clinical trial in Abu Dhabi. WAM
Al Etihad
18-04-2025
- Al Etihad
UAE healthcare sector advances in 2025 with rare surgeries, innovative treatments
18 Apr 2025 14:13 ABU DHABI (WAM)The UAE's healthcare sector has reinforced its leading position since the beginning of the year through a series of rare surgical procedures and the adoption of innovative treatments for critical illnesses, underscoring the high calibre of medical expertise across various UAE has transformed its healthcare system into a globally advanced model by investing in cutting-edge technologies such as artificial intelligence, therapeutic robots, and 3D printing to enhance the quality and sustainability of College Hospital London Dubai announced on Thursday the city's first liver transplant on an infant, a 13-month-old child, with the support of Al Jalila Foundation – the philanthropic arm of Dubai Health. The child was born with a rare condition known as biliary atresia, which caused his health to deteriorate despite an earlier surgical procedure to connect his liver to his intestines. He was also diagnosed with a congenital heart defect (atrial septal defect). The child was referred to King's College Hospital in Dubai by Al Jalila Children's Hospital, following the cardiac repair Clinic Abu Dhabi performed the world's first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer. Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound January, Cleveland Clinic Abu Dhabi also announced the UAE's first simultaneous robotic kidney transplant procedure for a donor and recipient using one Hospital has successfully performed a minimally invasive laparoscopic procedure for egg collection and freezing, a cutting-edge technique representing a significant leap forward in reproductive UAE's medical sector has also seen significant progress in implementing new and innovative treatments this year. In January, the Abu Dhabi Stem Cells Centre reported promising results in treating Type 1 diabetes using umbilical cord-derived mesenchymal stem cell (UC-MSC) Emirates Health Services (EHS) unveiled two innovative projects – an Artificial Heart Transplantation and an Pancreatic Cell Transplantation at Arab Health 2025 in April, the Department of Health – Abu Dhabi also completed a groundbreaking clinical trial in Abu Dhabi. The treatment, StromaForte, has shown a favourable safety profile and significant therapeutic potential for knee osteoarthritis, marking a significant step in evaluating cell-based therapies for degenerative joint diseases.M42, a leading global health technology company powered by AI, is meanwhile set to build a heavy ion therapy facility at Cleveland Clinic Abu Dhabi, bringing one of the most advanced and effective cancer treatment technologies to the Middle East. During Abu Dhabi Global Healthcare Week 2025, which concluded on Thursday, Cleveland Clinic Abu Dhabi also unveiled initiatives and new technologies to improve cancer patient care, including an innovative remote monitoring programme, using the BioButton wearable device, for cancer patients at the Fatima Bint Mubarak Centre.
